Clinical efficacy and safety of eravacycline for the treatment of enterococcal infections: a subpopulation analysis

Sean R. Van Helden, Ashlan J. Kunz Coyne, Sara Alosaimy, Kyle C. Molina, S. Lena Kang-Birken, Justin Andrade, Madeline A. King, Kimberly C. Claeys, Athena L. V. Hobbs, Nicholson B. Perkins III, Jazmin Agee, Alaina DeKerlegand, Mark Biagi, Michael P. Veve, Serina Tart, Tristan Gore, Bruce M. Jones, Benjamin M. Pullinger, Melanie Rae Schrack, Reese Cosimi, Shelbye R. Herbin, Chloe Judd, Mohammed Al Musawa, Michael J. Rybak

Open source

DOI
10.1186/s12879-025-11982-4
Published
2025-12-29
Container
BMC Infectious Diseases
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12879-025-11982-4,
  title = {Clinical efficacy and safety of eravacycline for the treatment of enterococcal infections: a subpopulation analysis},
  author = {Sean R. Van Helden and Ashlan J. Kunz Coyne and Sara Alosaimy and Kyle C. Molina and S. Lena Kang-Birken and Justin Andrade and Madeline A. King and Kimberly C. Claeys and Athena L. V. Hobbs and Nicholson B. Perkins III and Jazmin Agee and Alaina DeKerlegand and Mark Biagi and Michael P. Veve and Serina Tart and Tristan Gore and Bruce M. Jones and Benjamin M. Pullinger and Melanie Rae Schrack and Reese Cosimi and Shelbye R. Herbin and Chloe Judd and Mohammed Al Musawa and Michael J. Rybak},
  year = {2025},
  journal = {BMC Infectious Diseases},
  doi = {10.1186/s12879-025-11982-4},
  url = {https://doi.org/10.1186/s12879-025-11982-4}
}

RIS

TY  - JOUR
TI  - Clinical efficacy and safety of eravacycline for the treatment of enterococcal infections: a subpopulation analysis
AU  - Sean R. Van Helden
AU  - Ashlan J. Kunz Coyne
AU  - Sara Alosaimy
AU  - Kyle C. Molina
AU  - S. Lena Kang-Birken
AU  - Justin Andrade
AU  - Madeline A. King
AU  - Kimberly C. Claeys
AU  - Athena L. V. Hobbs
AU  - Nicholson B. Perkins III
AU  - Jazmin Agee
AU  - Alaina DeKerlegand
AU  - Mark Biagi
AU  - Michael P. Veve
AU  - Serina Tart
AU  - Tristan Gore
AU  - Bruce M. Jones
AU  - Benjamin M. Pullinger
AU  - Melanie Rae Schrack
AU  - Reese Cosimi
AU  - Shelbye R. Herbin
AU  - Chloe Judd
AU  - Mohammed Al Musawa
AU  - Michael J. Rybak
PY  - 2025
JO  - BMC Infectious Diseases
DO  - 10.1186/s12879-025-11982-4
UR  - https://doi.org/10.1186/s12879-025-11982-4
ER  - 

APA

Helden, S. R. V., Coyne, A. J. K., Alosaimy, S., Molina, K. C., Kang-Birken, S. L., Andrade, J., King, M. A., Claeys, K. C., Hobbs, A. L. V., III, N. B. P., Agee, J., DeKerlegand, A., Biagi, M., Veve, M. P., Tart, S., Gore, T., Jones, B. M., Pullinger, B. M., Schrack, M. R., Cosimi, R., Herbin, S. R., Judd, C., Musawa, M. A., & Rybak, M. J. (2025). Clinical efficacy and safety of eravacycline for the treatment of enterococcal infections: a subpopulation analysis. BMC Infectious Diseases. https://doi.org/10.1186/s12879-025-11982-4

Source records